Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
8.00
-0.33 (-3.96%)
Dec 5, 2025, 4:00 PM EST - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $139.80 million as of December 5, 2025. Its market cap has increased by 149.71% in one year.
Market Cap
139.80M
Enterprise Value
134.25M
1-Year Change
149.71%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $139.80M, a decrease of -55.22%. That is a compound annual growth rate of -27.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 139.80M | 154.36% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |